期刊文献+

不同生精功能和取精方式对无精子症ICSI妊娠结局的影响 被引量:3

Outcomes of azoospermia with different spermatogenesis ability treated by intracytoplasmic injection with sperm from epididymis and testis
暂未订购
导出
摘要 目的分析采用经皮附睾精子抽吸术(PESA)或经皮睾丸精子抽吸术(TESA)获得精子对不同生精功能无精子症进行卵泡浆内单精子注射(ICSI)治疗的妊娠结局。方法经PESA获得附睾精子,经TESA获得睾丸精子,女方进行常规超排卵。两种取精方法获得的精子进行ICSI,比较其妊娠率。结果 216次采用PESA获得附睾精子,87次采用TESA获得睾丸精子,PESA和TESA组的妊娠率分别为41.7%和43.7%,(P>0.05)。随着生精功能状态从正常到重度生精功能障碍的变化,其妊娠率依次为:46.8%,41.6%,36.7%和16.7%。其中生精功能正常组与轻度和中度生精功能障碍组差异无统计学意义,但与重度生精功能障碍组差异均有统计学意义。结论采用PESA或TESA结合ICSI是治疗男性无精子症的有效方法,而且认为生精功能正常组和轻度及中度生精功能障碍三组无精子症患者均可试行ICSI。 Objiective To analyze the outcomes of azoospemia patient with different spermatogenesis ability treated by intracytoplasmic injection with sperm from epididymis and testis. Methods Sperm retrieval were from epididymis by PESA and from testis by TESA, then the patients received ICSI for treatment of infertility. The rate of pregnancy was analyzed. Results The rates of pregnancy in PESA group and TESA group were 41.7% and 43.7% respectively (P〉 0.05). According to spermatogenesis ability, the rates of pregnancy were changed as follows: 48.9%, 40.6%, 34.0% and 14.3%. There were no significant differences in the rate of pregnancy among the normal groups, the mild group with spermatogenic dysfunction and the moderate group with spermatogenic dysfunction, but significant difference between the severe group with spermatogenic dysfunction and other groups. Conclusion The combination of ICSI with PESA or TESA might be an effective way to treat azoospermia patients with normal,mild and moderate spermatogenic dysfunction.
出处 《中国男科学杂志》 CAS CSCD 2010年第2期35-38,共4页 Chinese Journal of Andrology
基金 国家自然科学基金资助项目(No.30772167) 广州市科技计划项目(2008J1-C131)
关键词 无精子症 精子注射 细胞质内 妊娠 azoospermia sperm injections, intracytoplasmic pregnancy
  • 相关文献

参考文献15

二级参考文献93

共引文献82

同被引文献35

  • 1许张晔,叶碧绿,黄学峰,林文琴,林金菊,赵军招.不同来源精子对ICSI治疗后妊娠结局的影响[J].中国男科学杂志,2007,21(1):41-44. 被引量:17
  • 2陈士岭,黎淑贞,孙玲,宋华东,何锦霞,孔令红,朱亮,李红,邢福祺.1274例体外受精-胚胎移植治疗分娩新生儿结局分析[J].南方医科大学学报,2007,27(4):439-441. 被引量:17
  • 3吴明章.男性生殖病理学[M].上海:上海科学普及出版社,1996..
  • 4Jarow JP, Espeland MA, Lipshultz LI. Evaluation of the azoospermic patient. J Urol, 1989, 142(1) : 62-65.
  • 5Laboratory Manual of the WHO for the Examination of Human Semen and Sperm-cervical Mucus Interaction. Ann 1st Super Sanita, 2001,37(1): 1-123.
  • 6Tomas C, Orava M, Tuomivaara L, et al. Low pregnancy rate is achieved in patients treated with intracytoplasmic sperm injection due to previous low or failed fertilization in in-vitro fertilization. Hum Reprod, 1998, 13(1) : 65-70.
  • 7Devroey P, Van Steirteghem A. A review of ten years experience of ICSI. Hum Reprod Update, 2004, 10( 1 ) : 19-28.
  • 8Sofikitis NV, Miyagawa I, Agapitos E, et al. Reproductive capacity of the nucleus of the male gamete after completion of meiosis. J Assist Reprod Genet, 1994, 11 (7) : 335-341.
  • 9Moskovtsev SI, Jarvi K, MuUen JB, et al. Testicular spermatozoa have statistically significantly lower DNA damage compared with ejaculated spermatozoa in patients with unsuccessful oral antioxidant treatment. Fertil Steril, 2010, 93(4) : 1142-1145.
  • 10Donoso P, Tournaye H, Devroey P. Which is the best sperm retrieval technique for non-obstructive azoospermia? A systematic review. Hum Reprod Update, 2007, 13 (6) : 539-549.

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部